SBI Securities
QUIT icon

SBI Securities’s Achieve Life Sciences QUIT Stock Holding History

SBI Securities’s Portfolio QUIT Stock Details QUIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$121K Buy
14,965
+124
+0.8% +$887 ﹤0.01% 834
2026
Q2 		$96.9K Buy
14,841
+732
+5% +$3.49K ﹤0.01% 929
2026
Q1 		$41.5K Buy
14,109
+68
+0.5% +$302 ﹤0.01% 1173
2025
Q4 		$69.8K Buy
14,041
+1
+0% +$4 ﹤0.01% 961
2025
Q3 		$44.2K Buy
14,040
+17
+0.1% +$47 ﹤0.01% 1137
2025
Q2 		$31.7K Hold
14,023
– – ﹤0.01% 1235
2025
Q1 		$37.4K Hold
14,023
– – ﹤0.01% 1085
2024
Q4 		$49.4K Buy
+14,023
New +$63.5K ﹤0.01% 994

Other funds holding QUIT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

SBI Securities's QUIT Position: Q3 2026 in Review

SBI Securities increased its Achieve Life Sciences (QUIT) stake by 0.84% in Q3 2026, buying an estimated $887 and bringing the position to 14,965 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #834.

SBI Securities first reported a position in QUIT in Q4 2024 and has held it in 8 quarters since. 42 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

  • SBI Securities held 14,965 shares of Achieve Life Sciences worth $121K as of Q3 2026.
  • SBI Securities bought 124 Achieve Life Sciences shares in Q3 2026, an estimated $887.
  • Achieve Life Sciences made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #834 holding.
  • SBI Securities first reported a position in Achieve Life Sciences in Q4 2024 and has held it in 8 quarters since.
  • 42 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.